A novel PAX6 variant as the cause of aniridia in a Chinese patient with SRRRD

BMC Med Genomics. 2023 Aug 4;16(1):182. doi: 10.1186/s12920-023-01620-w.

Abstract

Background: The genotype characteristics and their associated clinical phenotypes in patients with aniridia were analyzed to explore pathogenic variants using whole-exome sequencing.

Methods: One patient with aniridia was enrolled at the Beijing Tongren Hospital. Comprehensive ophthalmic and general examinations were performed on the patient. DNA was extracted from the patient, and whole-exome sequencing was performed to identify the causative variant. The pathogenicity of the variant was predicted using in silico analysis and evaluated according to American College of Medical Genetics and Genomics guidelines. Relationships between genetic variants and clinical features were analyzed.

Results: In addition to the classical aniridia phenotype showing complete iris aplasia, foveal hypoplasia, and ectopic lentis, the patient also exhibited spontaneous reattachment rhegmatogenous retinal detachment (SRRRD). Whole-exome sequencing identified a novel heterozygous variant, exon8:c.640_646del:p.R214Pfs*28.

Conclusions: The present study broadens the range of genetic variants described in aniridia and presents an aniridia patient with SRRRD.

Keywords: Aniridia; PAX6; Spontaneous reattachment rhegmatogenous retinal detachment.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniridia* / complications
  • Aniridia* / genetics
  • Aniridia* / pathology
  • East Asian People
  • Genotype
  • Homeodomain Proteins / genetics
  • Humans
  • Mutation
  • PAX6 Transcription Factor / genetics
  • Pedigree
  • Retinal Detachment*

Substances

  • Homeodomain Proteins
  • PAX6 protein, human
  • PAX6 Transcription Factor